Boğaziçi CT3 has a clear national mandate of hosting research/researchers focusing on "targeted treatment technologies (T3)" and to thrive to become a worldwide pioneer of novel technologies in this field. It was spun out from Boğaziçi University Life Sciences and Technologies Application and Research Center (Boğaziçi LifeSci) within the last months of 2024, and has begun to receive a special financial support as a thematic Center of Excellence (Law #6550 of Turkey) . All groundbreaking T3 research/technological advancements, such as in vivo "smart" devices, targeted nanomedicine and special cellular treatments, will be boosted to be translated into clinical use and economic value!
Company Details
- Employees
- 11
- Founded
- -
- Address
- Boğaziçi Üniversitesi Kandilli Kampüsü, Derin Teknoloji Üssü, Bogazici Kandilli Kampüsü,çengelköy,turkey
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://httm.bogazici.edu.tr
- Keywords
- Beşiktaş.
- HQ
- İstanbul, Türkiye
Center For Targeted Therapy Technologies - Ct3 Questions
Center For Targeted Therapy Technologies - Ct3's website is https://httm.bogazici.edu.tr
Center For Targeted Therapy Technologies - Ct3's LinkedIn profile is https://tr.linkedin.com/company/bogazicict3
Center For Targeted Therapy Technologies - Ct3 has
11 employees.
View email and phone details for 11
employees at Center For Targeted Therapy Technologies - Ct3.
Center For Targeted Therapy Technologies - Ct3's industry is
Biotechnology Research
Center For Targeted Therapy Technologies - Ct3's top competitors are
Boğaziçi Üniversitesi Teknoloji Transfer Ofisi,
Centervet Veteriner Kliniği,
Bio-X "akademi-Endüstri Ağı",
Vetqom Hayvan Sağlığı,
Rs Research,
Kuttam,
Health Institutes Of Türkiye,
Ki̇m Grup,
Bloocell®,
Innorare.
Center For Targeted Therapy Technologies - Ct3's categories are Biotechnology Research
Center For Targeted Therapy Technologies - Ct3's founding year is 2010
